<DOC>
	<DOCNO>NCT00606034</DOCNO>
	<brief_summary>Patients Type 2 diabetes severe insulin resistance large insulin requirement fail previous insulin regimen use non-concentrated form insulin ( U100 insulin formulation ) receive 5X concentrated insulin ( U500 regular insulin ) infuse via insulin pump .</brief_summary>
	<brief_title>U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod</brief_title>
	<detailed_description>Patients Type 2 diabetes severe insulin resistance large insulin requirement ( 1.4 unit insulin /kg/day ) often fail insulin regimens persistent poor blood glucose control standard U-100 insulin formulation use . This due part poor absorption large insulin volume require use less concentrated standard insulin preparation . The hypothesis use concentrated form insulin call U-500 Regular insulin deliver infusion via insulin pump lower volume insulin require therefore improve insulin absorption , lead improve blood glucose control , test .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 2 diabetes stable insulin regimen without oral agent least 3 month HbA1c &gt; 7 % No significant cardiovascular , renal serious medical disease HbA1c &lt; 7 % Chronic renal , hepatic , cardiovascular , serious medical illness Females childbearing age use adequate contraception Use GLP mimetic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Continuous Subcutaneous Insulin Infusion</keyword>
	<keyword>U-500 Insulin</keyword>
	<keyword>Omnipod</keyword>
</DOC>